Induction of differentiation of human myeloid leukemias by phorbol diesters: phenotypic changes and mode of action. 1982

G Rovera, and D Ferrero, and G L Pagliardi, and J Vartikar, and S Pessano, and L Bottero, and S Abraham, and D Lebman

Treatment with 12-O-tetradecanoyl-phorbol-13-acetate (TPA) of acute myeloblastic leukemia cells halts proliferation and induces expression of monocyte/macrophage markers. Surface characteristics of leukemic HL60 cells, as defined using a panel of monoclonal antibodies, were found to be similar to those of normal human promyelocytes. TPA treatment, however, induced a phenotype that, unlike normal monocytes, contained several myeloid-specific markers and lacked several monocyte-specific markers. TPA treatment of HL60 cells causes the rapid disappearance of the transferrin receptor from the cell surface. Because transferrin is essential for HL60 cell proliferation in culture, the disappearance of this receptor is followed by an irreversible accumulation of the cells in the G1 phase of the cell cycle. The TPA-induced arrest of cell proliferation suggests the potential of this agent in experimentally treating myeloblastic leukemias.

UI MeSH Term Description Entries
D007399 Interphase The interval between two successive CELL DIVISIONS during which the CHROMOSOMES are not individually distinguishable. It is composed of the G phases (G1 PHASE; G0 PHASE; G2 PHASE) and S PHASE (when DNA replication occurs). Interphases
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D010704 Phorbols The parent alcohol of the tumor promoting compounds from CROTON OIL (Croton tiglium). Tigliane,Tiglianes
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G Rovera, and D Ferrero, and G L Pagliardi, and J Vartikar, and S Pessano, and L Bottero, and S Abraham, and D Lebman
November 1984, Journal of the National Cancer Institute,
G Rovera, and D Ferrero, and G L Pagliardi, and J Vartikar, and S Pessano, and L Bottero, and S Abraham, and D Lebman
July 1988, Blood,
G Rovera, and D Ferrero, and G L Pagliardi, and J Vartikar, and S Pessano, and L Bottero, and S Abraham, and D Lebman
January 1982, Carcinogenesis,
G Rovera, and D Ferrero, and G L Pagliardi, and J Vartikar, and S Pessano, and L Bottero, and S Abraham, and D Lebman
July 1983, Journal of immunology (Baltimore, Md. : 1950),
G Rovera, and D Ferrero, and G L Pagliardi, and J Vartikar, and S Pessano, and L Bottero, and S Abraham, and D Lebman
January 1985, Medical oncology and tumor pharmacotherapy,
G Rovera, and D Ferrero, and G L Pagliardi, and J Vartikar, and S Pessano, and L Bottero, and S Abraham, and D Lebman
November 1979, Cancer research,
G Rovera, and D Ferrero, and G L Pagliardi, and J Vartikar, and S Pessano, and L Bottero, and S Abraham, and D Lebman
March 1984, Cancer research,
G Rovera, and D Ferrero, and G L Pagliardi, and J Vartikar, and S Pessano, and L Bottero, and S Abraham, and D Lebman
January 1982, Carcinogenesis; a comprehensive survey,
G Rovera, and D Ferrero, and G L Pagliardi, and J Vartikar, and S Pessano, and L Bottero, and S Abraham, and D Lebman
March 1977, Annals of the New York Academy of Sciences,
G Rovera, and D Ferrero, and G L Pagliardi, and J Vartikar, and S Pessano, and L Bottero, and S Abraham, and D Lebman
October 1984, International journal of cancer,
Copied contents to your clipboard!